vs
美敦力（MDT）与信安金融集团（PFG）财务数据对比。点击上方公司名可切换其他公司
美敦力的季度营收约是信安金融集团的2.0倍（$9.0B vs $4.6B），美敦力净利率更高（15.3% vs 11.3%，领先4.0%），美敦力同比增速更快（6.6% vs -3.7%），过去两年信安金融集团的营收复合增速更高（6.3% vs 5.3%）
美敦力是全球知名的医疗设备企业，法定及行政总部位于爱尔兰，运营总部设在美国明尼苏达州明尼阿波利斯。2015年集团收购爱尔兰企业柯惠后将注册地迁至爱尔兰，目前业务覆盖超150个国家，员工逾9万名，专注于研发生产各类医疗技术产品及治疗解决方案。
信安金融集团（股票代码：PFG）是总部位于美国艾奥瓦州得梅因的全球性金融服务企业，核心业务涵盖投资管理、保险服务两大板块，在全球多个区域开展业务，为机构客户和个人用户提供专业定制化的金融解决方案，在行业内拥有较高知名度。
MDT vs PFG — 直观对比
营收规模更大
MDT
是对方的2.0倍
$4.6B
营收增速更快
MDT
高出10.3%
-3.7%
净利率更高
MDT
高出4.0%
11.3%
两年增速更快
PFG
近两年复合增速
5.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.0B | $4.6B |
| 净利润 | $1.4B | $517.0M |
| 毛利率 | 65.8% | — |
| 营业利润率 | 18.8% | — |
| 净利率 | 15.3% | 11.3% |
| 营收同比 | 6.6% | -3.7% |
| 净利润同比 | 8.2% | -42.9% |
| 每股收益（稀释后） | $1.07 | $2.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDTPFG
| Q4 25 | $9.0B | $4.6B | ||
| Q3 25 | $8.6B | $3.7B | ||
| Q2 25 | $8.9B | $3.7B | ||
| Q1 25 | $8.3B | $3.7B | ||
| Q4 24 | $8.4B | $4.8B | ||
| Q3 24 | $7.9B | $3.0B | ||
| Q2 24 | $8.6B | $4.3B | ||
| Q1 24 | $8.1B | $4.1B |
净利润MDTPFG
| Q4 25 | $1.4B | $517.0M | ||
| Q3 25 | $1.0B | $213.8M | ||
| Q2 25 | $1.1B | $406.2M | ||
| Q1 25 | $1.3B | $48.1M | ||
| Q4 24 | $1.3B | $905.4M | ||
| Q3 24 | $1.0B | $-220.0M | ||
| Q2 24 | $654.0M | $353.1M | ||
| Q1 24 | $1.3B | $532.5M |
毛利率MDTPFG
| Q4 25 | 65.8% | — | ||
| Q3 25 | 65.0% | — | ||
| Q2 25 | 64.8% | — | ||
| Q1 25 | 66.5% | — | ||
| Q4 24 | 64.9% | — | ||
| Q3 24 | 65.1% | — | ||
| Q2 24 | 64.5% | — | ||
| Q1 24 | 65.6% | — |
营业利润率MDTPFG
| Q4 25 | 18.8% | — | ||
| Q3 25 | 16.8% | — | ||
| Q2 25 | 16.1% | — | ||
| Q1 25 | 19.9% | — | ||
| Q4 24 | 19.0% | — | ||
| Q3 24 | 16.1% | — | ||
| Q2 24 | 12.3% | — | ||
| Q1 24 | 18.3% | — |
净利率MDTPFG
| Q4 25 | 15.3% | 11.3% | ||
| Q3 25 | 12.1% | 5.8% | ||
| Q2 25 | 11.8% | 11.1% | ||
| Q1 25 | 15.6% | 1.3% | ||
| Q4 24 | 15.1% | 19.1% | ||
| Q3 24 | 13.2% | -7.3% | ||
| Q2 24 | 7.6% | 8.2% | ||
| Q1 24 | 16.3% | 13.1% |
每股收益（稀释后）MDTPFG
| Q4 25 | $1.07 | $2.30 | ||
| Q3 25 | $0.81 | $0.95 | ||
| Q2 25 | $0.81 | $1.79 | ||
| Q1 25 | $1.01 | $0.21 | ||
| Q4 24 | $0.99 | $3.92 | ||
| Q3 24 | $0.80 | $-0.95 | ||
| Q2 24 | $0.50 | $1.49 | ||
| Q1 24 | $0.99 | $2.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.3B | $4.4B |
| 总债务越低越好 | $27.7B | $3.9B |
| 股东权益账面价值 | $48.7B | $11.9B |
| 总资产 | $91.3B | $341.4B |
| 负债/权益比越低杠杆越低 | 0.57× | 0.33× |
8季度趋势，按日历期对齐
现金及短期投资MDTPFG
| Q4 25 | $8.3B | $4.4B | ||
| Q3 25 | $8.1B | $5.1B | ||
| Q2 25 | $9.0B | $3.7B | ||
| Q1 25 | $7.9B | $3.9B | ||
| Q4 24 | $8.0B | $4.2B | ||
| Q3 24 | $7.8B | $6.2B | ||
| Q2 24 | $8.0B | $4.8B | ||
| Q1 24 | $8.3B | $4.2B |
总债务MDTPFG
| Q4 25 | $27.7B | $3.9B | ||
| Q3 25 | $26.2B | $3.9B | ||
| Q2 25 | $25.6B | $3.9B | ||
| Q1 25 | $24.0B | $4.3B | ||
| Q4 24 | $24.6B | $4.0B | ||
| Q3 24 | $26.3B | $3.9B | ||
| Q2 24 | $23.9B | $3.9B | ||
| Q1 24 | $24.2B | $3.9B |
股东权益MDTPFG
| Q4 25 | $48.7B | $11.9B | ||
| Q3 25 | $47.9B | $11.7B | ||
| Q2 25 | $48.0B | $11.4B | ||
| Q1 25 | $49.4B | $11.2B | ||
| Q4 24 | $48.5B | $11.1B | ||
| Q3 24 | $47.9B | $11.2B | ||
| Q2 24 | $50.2B | $11.0B | ||
| Q1 24 | $51.8B | $11.2B |
总资产MDTPFG
| Q4 25 | $91.3B | $341.4B | ||
| Q3 25 | $91.0B | $334.5B | ||
| Q2 25 | $91.7B | $323.1B | ||
| Q1 25 | $90.0B | $313.0B | ||
| Q4 24 | $90.0B | $313.7B | ||
| Q3 24 | $89.7B | $322.9B | ||
| Q2 24 | $90.0B | $308.8B | ||
| Q1 24 | $90.8B | $308.7B |
负债/权益比MDTPFG
| Q4 25 | 0.57× | 0.33× | ||
| Q3 25 | 0.55× | 0.34× | ||
| Q2 25 | 0.53× | 0.34× | ||
| Q1 25 | 0.49× | 0.39× | ||
| Q4 24 | 0.51× | 0.36× | ||
| Q3 24 | 0.55× | 0.35× | ||
| Q2 24 | 0.48× | 0.36× | ||
| Q1 24 | 0.47× | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $925.0M | $1.7B |
| 自由现金流经营现金流 - 资本支出 | $457.0M | — |
| 自由现金流率自由现金流/营收 | 5.1% | — |
| 资本支出强度资本支出/营收 | 5.2% | — |
| 现金转化率经营现金流/净利润 | 0.67× | 3.37× |
| 过去12个月自由现金流最近4个季度 | $5.2B | — |
8季度趋势，按日历期对齐
经营现金流MDTPFG
| Q4 25 | $925.0M | $1.7B | ||
| Q3 25 | $1.1B | $1.0B | ||
| Q2 25 | $2.5B | $811.9M | ||
| Q1 25 | $2.6B | $977.3M | ||
| Q4 24 | $958.0M | $1.5B | ||
| Q3 24 | $986.0M | $1.1B | ||
| Q2 24 | $2.8B | $1.4B | ||
| Q1 24 | $2.5B | $584.2M |
自由现金流MDTPFG
| Q4 25 | $457.0M | — | ||
| Q3 25 | $584.0M | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $554.0M | — | ||
| Q3 24 | $466.0M | — | ||
| Q2 24 | $2.4B | — | ||
| Q1 24 | $2.1B | — |
自由现金流率MDTPFG
| Q4 25 | 5.1% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 23.2% | — | ||
| Q1 25 | 25.3% | — | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 27.4% | — | ||
| Q1 24 | 26.3% | — |
资本支出强度MDTPFG
| Q4 25 | 5.2% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 5.0% | — | ||
| Q1 24 | 4.3% | — |
现金转化率MDTPFG
| Q4 25 | 0.67× | 3.37× | ||
| Q3 25 | 1.05× | 4.70× | ||
| Q2 25 | 2.39× | 2.00× | ||
| Q1 25 | 1.99× | 20.32× | ||
| Q4 24 | 0.75× | 1.61× | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | 4.25× | 4.05× | ||
| Q1 24 | 1.87× | 1.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDT
| Cardiac Rhythm And Heart Failure Division | $1.8B | 20% |
| Surgical Endoscopy | $1.7B | 19% |
| Other | $1.3B | 14% |
| Structural Heart And Aortic Division | $956.0M | 11% |
| Diabetes Group | $757.0M | 8% |
| Specialty Therapies Division | $744.0M | 8% |
| Coronary And Peripheral Vascular Division | $655.0M | 7% |
| Neuromodulation Division | $520.0M | 6% |
| Acute Care Monitoring | $493.0M | 6% |
| IE | $35.0M | 0% |
PFG
| Segment Retirement And Income Solutions | $1.6B | 36% |
| Segment Benefits And Protection | $1.1B | 23% |
| Other | $582.8M | 13% |
| Segment Principal Asset Management | $465.6M | 10% |
| Subsegment Investment Management | $449.4M | 10% |
| Administrative Service | $152.2M | 3% |
| Subsegment International Pension | $91.2M | 2% |
| Segment Corporate | $73.0M | 2% |
| Subsegment Life Insurance | $26.1M | 1% |
| Financial Service Other | $25.1M | 1% |
| Residential Mortgage | $7.4M | 0% |
| Subsegment Specialty Benefits | $3.7M | 0% |
| Deposit Account | $3.4M | 0% |
| Commission Income | $1.8M | 0% |
